Funded projects

Current

Targets for cancer therapy by integration of gene expression and toxicity data. Naturwissenschaftlich-Medizinische Forschungszentrum and JGU. Started Jan. 2017.

Pharmacological prevention of preeclampsia and preeclampsia-induced epigenetic fetal programming.
Naturwissenschaftlich-Medizinische Forschungszentrum and JGU. To start in 2017.

COST Action BM1405: Non-globular proteins: from sequence to structure, function and application in molecular physiopathology. European Union; European Cooperation in the field of Scientific and Technical Research - COST. Started Jan. 2015.

SysToxChip: Individualized microfluidic multiorgan chip for the analysis of drug induced toxicity towards improved drug safety. BMBF; e:Bio. Started Nov. 2014.

SPP1463: Epigenetic Regulation of normal hematopoiesis and its dysregulation in myeloid neoplasia. DFG. Started: November 2010. http://www.myeloid-epigenetics.de/